← 產業報告目錄

Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-05-26頁數 373報告編號 MD7656

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The veterinary PoC diagnostics market is expected to grow from USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. This growth is driven by several key factors shaping the future of rapid veterinary diagnostics, decentralized testing, and real-time animal health management. The veterinary PoC diagnostics market is primarily driven by increasing focus on disease identification at the point of care in companion and farm animals, fueling the need for rapid clinical decision-making. The growing trend of pet ownership and livestock intensification is pushing veterinarians and animal health service providers to emphasize early detection and regular health monitoring, helping them reduce the disease burden and improve treatment management. Consequently, veterinary clinics, farms and field veterinarians are increasingly employing point-of-care instruments such as rapid immunoassays, portable molecular systems, and handheld analyzers for rapid disease identification. Another key driver is the growing focus on animal health prevention, biosecurity and management of zoonotic and economically important diseases. Governments, veterinary associations, and animal owners are placing greater focus on disease monitoring and surveillance to reduce the number of disease outbreaks and safeguard food safety and public health. This is increasing the demand for PoC testing for rapid disease detection and treatment decision-making. In addition, while the current PoC diagnostic market is still in development, improvements in diagnostic technology, in particular smaller and more portable diagnostic devices, isothermal amplification techniques, and integrated digital platforms, are improving the potency and viability of PoC diagnostic tools. Developments including cartridge-based approaches, ready-to-use diagnostic kits, and connected diagnostic devices will greatly reduce testing times, automate processes, and make the wider use of PoC diagnostics more feasible. By animal type, companion animals to record higher CAGR during forecast period The companion animals segment is expected to witness a higher growth rate in the veterinary PoC diagnostics market due to the rising global pet population and increasing humanization of pets, leading to higher spending on advanced veterinary care. Pet owners are increasingly demanding rapid, in-clinic diagnostics for early disease detection and immediate treatment decisions, driving adoption of PoC technologies in veterinary clinics. Additionally, greater awareness of preventive healthcare, frequent veterinary visits, and the availability of advanced, user-friendly diagnostic solutions tailored for companion animals are further accelerating growth in this segment. By technology, immunodiagnostics segment accounted for largest market share in 2025 In 2025, the immunodiagnostics segment dominated the veterinary PoC diagnostics market due to its widespread use in rapid, easy-to-perform testing formats such as lateral flow assays and ELISA-based kits. These tests are commonly used to detect infectious diseases, parasites, and biomarkers across both companion and livestock animals, making them integral to routine veterinary practice. Their advantages, including quick turnaround time, cost-effectiveness, minimal sample preparation, and suitability for in-clinic and field settings without advanced infrastructure, drive high adoption volumes and make immunodiagnostics the dominant segment in the market. Asia Pacific to witness highest growth rate during forecast period The Asia Pacific region is growing at the fastest rate in the veterinary PoC diagnostics market. The main reason for this is due to rising livestock production, pet ownership, and awareness of animal health management in emerging countries of the region. Pet adoption is increasing in many emerging nations, coupled with the rising use of portable, rapid diagnostic products in clinical and farm settings due to expanding veterinary infrastructure and government initiatives for disease surveillance and control. The growing incidence of infectious and zoonotic diseases and an increase in investments by global and regional players are leading to the wide adoption of portable, user-friendly veterinary PoC diagnostics. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%) • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers. Breakdown of demand-side primary interviews: • By End User: Veterinary Hospitals & Clinics (50%), Homecare Settings (35%), Other End Users (15%) By Designation: Veterinarians/Veterinary Practitioners (47%), Veterinary Clinics or Hospital Directors/Owners (22%), Livestock Farm Managers/Animal Health Managers (15%), and Others (16%) • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%) Note: Other end users include academic and research institutes, livestock farm owners, and animal welfare organizations. Note: Other designations include laboratory technicians, practice managers, procurement officers, and academic researchers. Research Coverage The market study covers the veterinary PoC diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below. This report provides insights into the following points: • Analysis of key drivers (rising demand for rapid, on-site diagnosis and immediate clinical decision-making, increasing pet ownership and intensification of livestock production), restraints (limited sensitivity/accuracy compared to centralized laboratory testing in some cases, high cost of advanced PoC devices and limited adoption in low-income regions), opportunities (technological advancements in portable molecular diagnostics and biosensors, growing adoption in emerging markets with expanding veterinary infrastructure), and challenges (lack of standardization and regulatory variations across regions, limited skilled professionals for proper use and interpretation of PoC tests) influencing the growth of the veterinary PoC diagnostics market • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the veterinary PoC diagnostics market • Market Development: Comprehensive information about lucrative emerging markets by analyzing the markets for various types of PoC diagnostic products across regions • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary PoC diagnostics market • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary PoC diagnostics market
目錄 Table of Contents
1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 MARKET SCOPE 34 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 34 1.3.2 INCLUSIONS AND EXCLUSIONS 35 1.3.3 YEARS CONSIDERED 35 1.3.4 CURRENCY CONSIDERED 36 1.3.5 UNIT CONSIDERED 36 1.4 LIMITATIONS 36 1.5 STAKEHOLDERS 36 1.6 SUMMARY OF CHANGES 37 2 EXECUTIVE SUMMARY 38 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 38 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 39 2.3 DISRUPTIVE TRENDS IN VETERINARY POC DIAGNOSTICS MARKET 40 2.4 HIGH-GROWTH SEGMENTS 41 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 42 3 PREMIUM INSIGHTS 44 3.1 VETERINARY POC DIAGNOSTICS MARKET OVERVIEW 44 3.2 VETERINARY POC DIAGNOSTICS MARKET IN ASIA PACIFIC, BY PRODUCT AND COUNTRY 45 3.3 VETERINARY POC DIAGNOSTICS MARKET: REGIONAL MIX 46 3.4 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46 3.5 VETERINARY POC DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 47 4 MARKET OVERVIEW 48 4.1 INTRODUCTION 48 4.2 MARKET DYNAMICS 48 4.2.1 DRIVERS 49 4.2.1.1 Rising incidence of transboundary and endemic diseases 49 4.2.1.2 Increasing demand for animal-derived food products 49 4.2.1.3 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms 50 4.2.1.4 Growth in companion animal population 51 4.2.1.5 Rising demand for pet insurance and growing animal health expenditure 52   4.2.2 RESTRAINTS 53 4.2.2.1 Rising pet care costs 53 4.2.2.2 High cost of veterinary diagnostic tests 54 4.2.2.3 Limited diagnostic infrastructure in emerging economies 54 4.2.3 OPPORTUNITIES 55 4.2.3.1 Integration of AI & ML in veterinary PoC diagnostics 55 4.2.3.2 Expansion of rapid PoC and portable on-farm diagnostic solutions 55 4.2.4 CHALLENGES 56 4.2.4.1 Rapid mutation and strain variability of viral pathogens 56 4.3 UNMET NEEDS AND WHITE SPACES 56 4.3.1 UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET 56 4.3.2 WHITE SPACE OPPORTUNITIES 57 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 58 4.4.1 INTERCONNECTED MARKETS 58 4.4.2 CROSS-SECTOR OPPORTUNITIES 59 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60 4.5.1 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60 5 INDUSTRY TRENDS 61 5.1 PORTER’S FIVE FORCES ANALYSIS 61 5.1.1 THREAT OF NEW ENTRANTS 62 5.1.2 THREAT OF SUBSTITUTES 62 5.1.3 BARGAINING POWER OF SUPPLIERS 63 5.1.4 BARGAINING POWER OF BUYERS 63 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63 5.2 MACROECONOMIC OUTLOOK 64 5.2.1 INTRODUCTION 64 5.2.2 GDP TRENDS AND FORECAST 64 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 65 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 66 5.3 VALUE CHAIN ANALYSIS 66 5.4 ECOSYSTEM ANALYSIS 68 5.5 PRICING ANALYSIS 68 5.5.1 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 69 5.5.1.1 Pricing trend of veterinary PoC diagnostic products, by key player, 2023−2025 69 5.5.2 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025 69 5.5.2.1 Pricing trend of PCR kits, by region, 2023−2025 70 5.5.2.2 Pricing trend of immunodiagnostic veterinary POC products, by region, 2023−2025 70   5.6 TRADE ANALYSIS 71 5.6.1 TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS 72 5.6.1.1 Country-wise import data for HS code 3822-compliant products, 2021–2025 72 5.6.1.2 Country-wise export data for HS code 3822-compliant products, 2021–2025 72 5.7 KEY CONFERENCES AND EVENTS, 2026–2027 73 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74 5.9 INVESTMENT AND FUNDING SCENARIO 75 5.10 CASE STUDY ANALYSIS 76 5.10.1 USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 76 5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION 77 5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION 77 5.11 IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET 78 5.11.1 INTRODUCTION 78 5.11.2 KEY TARIFF RATES 79 5.11.3 PRICE IMPACT ANALYSIS 80 5.11.4 IMPACT ON COUNTRY/REGION 80 5.11.5 IMPACT ON END USERS 82 5.11.5.1 Veterinary hospitals & clinics 82 5.11.5.2 Livestock producers & animal health networks 82 5.11.5.3 Home care settings 82 5.11.5.4 Other end users (mobile veterinary service providers, animal shelters, NGOs) 82 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83 6.1 KEY/EMERGING TECHNOLOGIES 83 6.1.1 CRISPR-BASED MOLECULAR DIAGNOSTICS 83 6.1.2 ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP 83 6.2 COMPLEMENTARY TECHNOLOGIES 84 6.2.1 MICROFLUIDICS & LAB-ON-A-CHIP DEVICES 84 6.2.2 BIOSENSOR-BASED DIAGNOSTIC SYSTEMS 84 6.3 ADJACENT TECHNOLOGIES 85 6.3.1 AI & MACHINE LEARNING 85 6.3.2 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES 85 6.4 TECHNOLOGY/PRODUCT ROADMAP 86 6.4.1 NEAR TERM (2025–2027) 86 6.4.2 MID TERM (2028–2030) 86 6.4.3 LONG TERM (2030+) 87 6.5 PATENT ANALYSIS 87 6.5.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS 87 6.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 88 6.6 FUTURE APPLICATIONS 90 6.6.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION 90 6.6.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS 91 6.6.3 MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS 91 6.6.4 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING 91 6.7 IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET 91 6.7.1 INTRODUCTION 91 6.7.2 MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM 92 6.7.3 AI USE CASES 92 6.7.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET 93 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 94 7.1 REGIONAL REGULATIONS AND COMPLIANCE 94 7.1.1 REGULATORY ANALYSIS 94 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 7.1.3 INDUSTRY STANDARDS 97 7.2 SUSTAINABILITY INITIATIVES 98 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 98 7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 98 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 99 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100 8.1 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100 8.1.1 DECISION-MAKING PROCESS 100 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 101 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 101 8.2.2 BUYING CRITERIA 101 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 103 8.3.1 UNMET NEEDS OF VARIOUS END USERS 104 8.4 MARKET PROFITABILITY 104   9 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT 106 9.1 INTRODUCTION 107 9.2 CONSUMABLES 109 9.2.1 INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND 109 9.2.2 GLOBAL VOLUME ANALYSIS OF CONSUMABLES, 2024–2031 (THOUSAND UNITS) 111 9.3 INSTRUMENTS 112 9.3.1 SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH 112 9.3.2 GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024–2031 (THOUSAND UNITS) 114 10 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE 115 10.1 INTRODUCTION 116 10.2 COMPANION ANIMALS 116 10.2.1 GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH 116 10.2.2 DOG 119 10.2.2.1 Increasing prevalence of canine infectious diseases to support rapid adoption of veterinary care 119 10.2.3 CAT 121 10.2.3.1 Growing awareness of feline infectious diseases to fuel market growth 121 10.2.4 HORSE 122 10.2.4.1 Need to prevent vertical pathogen transmission to stimulate use of extensive PCR surveillance solutions 122 10.2.5 OTHER COMPANION ANIMALS 124 10.3 LIVESTOCK 125 10.3.1 SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS 125 10.3.2 CATTLE 128 10.3.2.1 Increasing focus on improving milk quality, herd productivity, and biosecurity management to drive demand 128 10.3.3 PIG 130 10.3.3.1 Growing swine disease outbreaks to accelerate diagnostic utilization 130 10.3.4 POULTRY 131 10.3.4.1 Rrising concerns regarding zoonotic disease transmission to spur demand 131 10.3.5 OTHER LIVESTOCK 133   11 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY 135 11.1 INTRODUCTION 136 11.2 IMMUNODIAGNOSTICS 137 11.2.1 PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH 137 11.3 MOLECULAR DIAGNOSTICS 139 11.3.1 PCR-BASED 142 11.3.1.1 Increasing use of portable and multiplex PCR platforms to propel market 142 11.3.2 ISOTHERMAL AMPLIFICATION 143 11.3.2.1 Demand for rapid and low-infrastructure molecular testing to accelerate adoption 143 11.3.3 CRISPR-BASED 145 11.3.3.1 Emerging next-generation pathogen detection technologies to create growth potential 145 11.4 OTHER TECHNOLOGIES 146 12 VETERINARY POC DIAGNOSTICS MARKET, BY REGION 148 12.1 INTRODUCTION 149 12.2 NORTH AMERICA 150 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 151 12.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 152 12.2.3 US 155 12.2.3.1 High veterinary healthcare expenditure to drive market 155 12.2.4 CANADA 158 12.2.4.1 Growing pet adoption to drive market 158 12.3 EUROPE 161 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 162 12.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 162 12.3.3 GERMANY 165 12.3.3.1 Rising awareness of zoonotic diseases to fuel market growth 165 12.3.4 UK 169 12.3.4.1 Increasing pet ownership to stimulate demand 169 12.3.5 FRANCE 172 12.3.5.1 Willingness of pet owners to spend on pet health to promote market growth 172 12.3.6 ITALY 175 12.3.6.1 Growing consumption of meat and dairy products to drive market 175 12.3.7 SPAIN 178 12.3.7.1 Growing demand for poultry products to fuel market growth 178 12.3.8 NETHERLANDS 180 12.3.8.1 Developments in veterinary diagnostic products to support market growth 180 12.3.9 POLAND 183 12.3.9.1 Rapid expansion of poultry production and export-oriented farming to elevate demand 183 12.3.10 SWEDEN 186 12.3.10.1 Strong veterinary healthcare infrastructure and advanced animal welfare regulations to propel market 186 12.3.11 REST OF EUROPE 189 12.4 ASIA PACIFIC 191 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 193 12.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 194 12.4.3 CHINA 197 12.4.3.1 Increasing incidence of zoonotic diseases to propel market 197 12.4.4 JAPAN 200 12.4.4.1 Increasing pet expenditure to support market growth 200 12.4.5 INDIA 204 12.4.5.1 Increasing demand for dairy products to drive market 204 12.4.6 AUSTRALIA 207 12.4.6.1 Rise in pet ownership to support market growth 207 12.4.7 SOUTH KOREA 210 12.4.7.1 Rising need for specialized veterinary services to drive market 210 12.4.8 NEW ZEALAND 213 12.4.8.1 Focus on pet insurance to aid market 213 12.4.9 THAILAND 216 12.4.9.1 Growing focus on disease surveillance to drive market 216 12.4.10 REST OF ASIA PACIFIC 219 12.5 LATIN AMERICA 221 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 222 12.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 222 12.5.3 BRAZIL 225 12.5.3.1 Booming livestock industry to boost demand 225 12.5.4 MEXICO 228 12.5.4.1 Expanding poultry sector to support market growth 228 12.5.5 ARGENTINA 231 12.5.5.1 Expanding poultry production and increasing focus on disease monitoring to drive market 231 12.5.6 REST OF LATIN AMERICA 234 12.6 MIDDLE EAST & AFRICA 236 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 237 12.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 237 12.6.3 GCC COUNTRIES 240 12.6.3.1 Kingdom of Saudi Arabia (KSA) 243 12.6.3.1.1 Technology advancements in veterinary diagnostics to boost demand 243 12.6.3.2 United Arab Emirates (UAE) 245 12.6.3.2.1 Favorable government support for vet diagnostics to drive market 245 12.6.3.3 Rest of GCC Countries 248 12.6.4 REST OF MIDDLE EAST & AFRICA 250 13 COMPETITIVE LANDSCAPE 253 13.1 OVERVIEW 253 13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022–APRIL 2026 253 13.3 REVENUE ANALYSIS, 2021−2025 255 13.4 MARKET SHARE ANALYSIS, 2025 257 13.4.1 US MARKET SHARE ANALYSIS, 2025 259 13.4.2 EUROPE MARKET SHARE ANALYSIS, 2025 260 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 261 13.5.1 STARS 261 13.5.2 EMERGING LEADERS 261 13.5.3 PERVASIVE PLAYERS 261 13.5.4 PARTICIPANTS 261 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 263 13.5.5.1 Company footprint 263 13.5.5.2 Region footprint 264 13.5.5.3 Product footprint 265 13.5.5.4 Technology footprint 266 13.5.5.5 Animal type footprint 267 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 267 13.6.1 PROGRESSIVE COMPANIES 267 13.6.2 RESPONSIVE COMPANIES 268 13.6.3 DYNAMIC COMPANIES 268 13.6.4 STARTING BLOCKS 268 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 269 13.6.5.1 Detailed list of key startups/SMEs 269 13.6.5.2 Competitive benchmarking of key startups/SMEs 270 13.7 BRAND/PRODUCT COMPARISON 271 13.8 R&D EXPENDITURE OF KEY PLAYERS 272 13.9 COMPANY VALUATION AND FINANCIAL METRICS 272 13.9.1 FINANCIAL METRICS 272 13.9.2 COMPANY VALUATION 273 13.10 COMPETITIVE SCENARIO 273 13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 273 13.10.2 DEALS 274 13.10.3 EXPANSIONS 275 13.10.4 OTHER DEVELOPMENTS 276 14 COMPANY PROFILES 277 14.1 KEY PLAYERS 277 14.1.1 IDEXX LABORATORIES, INC. 277 14.1.1.1 Business overview 277 14.1.1.2 Products offered 279 14.1.1.3 Recent developments 279 14.1.1.3.1 Product launches/Approvals/Enhancements 279 14.1.1.4 MnM view 280 14.1.1.4.1 Key strengths 280 14.1.1.4.2 Strategic choices 280 14.1.1.4.3 Weaknesses & competitive threats 280 14.1.2 ZOETIS SERVICES LLC 281 14.1.2.1 Business overview 281 14.1.2.2 Products offered 282 14.1.2.3 Recent developments 283 14.1.2.3.1 Deals 283 14.1.2.3.2 Expansions 283 14.1.2.3.3 Other developments 284 14.1.2.4 MnM view 284 14.1.2.4.1 Key strengths 284 14.1.2.4.2 Strategic choices 284 14.1.2.4.3 Weaknesses & competitive threats 285 14.1.3 THERMO FISHER SCIENTIFIC INC. 286 14.1.3.1 Business overview 286 14.1.3.2 Products offered 287 14.1.3.3 MnM view 290 14.1.3.3.1 Key strengths 290 14.1.3.3.2 Strategic choices 291 14.1.3.3.3 Weaknesses & competitive threats 291 14.1.4 ANTECH DIAGNOSTICS, INC. 292 14.1.4.1 Business overview 292 14.1.4.2 Products offered 293 14.1.4.3 Recent developments 293 14.1.4.3.1 Product launches/Approvals/Enhancements 293 14.1.4.3.2 Expansions 294 14.1.4.4 MnM view 294 14.1.4.4.1 Key strengths 294 14.1.4.4.2 Strategic choices 294 14.1.4.4.3 Weaknesses & competitive threats 295 14.1.5 BIONOTE 296 14.1.5.1 Business overview 296 14.1.5.2 Products offered 296 14.1.5.3 Recent developments 298 14.1.5.4 Product launches/Approvals/Enhancements 298 14.1.5.4.1 Deals 299 14.1.5.5 MnM view 299 14.1.5.5.1 Key strengths 299 14.1.5.5.2 Strategic choices 299 14.1.5.5.3 Weaknesses & competitive threats 300 14.1.6 INNOVATIVE DIAGNOSTICS 301 14.1.6.1 Business overview 301 14.1.6.2 Products offered 301 14.1.6.3 Recent developments 302 14.1.6.3.1 Other developments 302 14.1.7 BIOMÉRIEUX 303 14.1.7.1 Business overview 303 14.1.7.2 Products offered 304 14.1.7.3 Recent developments 305 14.1.7.3.1 Product launches/Approvals/Enhancements 305 14.1.8 INDICAL BIOSCIENCE GMBH 306 14.1.8.1 Business overview 306 14.1.8.2 Products offered 306 14.1.8.3 Recent developments 308 14.1.8.3.1 Product launches/Approvals/Enhancements 308 14.1.9 VIRBAC 309 14.1.9.1 Business overview 309 14.1.9.2 Products offered 310 14.1.9.3 Recent developments 311 14.1.9.3.1 Deals 311 14.1.9.3.2 Expansions 311 14.1.10 MEGACOR DIAGNOSTIK GMBH 312 14.1.10.1 Business overview 312 14.1.10.2 Products offered 312 14.1.10.3 Recent developments 315 14.1.10.3.1 Product launches/Approvals/Enhancements 315 14.1.11 BIOGAL 316 14.1.11.1 Business overview 316 14.1.11.2 Products offered 316 14.1.12 RING BIOTECHNOLOGY CO., LTD. 318 14.1.12.1 Business overview 318 14.1.12.2 Products offered 318 14.1.12.3 Recent developments 325 14.1.12.3.1 Product launches/Approvals/Enhancements 325 14.1.12.3.2 Other developments 325 14.1.13 AGROLABO S.P.A. 326 14.1.13.1 Business overview 326 14.1.13.2 Products offered 326 14.1.14 ENALEES 328 14.1.14.1 Business overview 328 14.1.14.2 Products offered 328 14.1.14.3 Recent developments 331 14.1.14.3.1 Product launches/Approvals/Enhancements 331 14.1.14.3.2 Deals 331 14.1.14.3.3 Expansions 332 14.1.14.3.4 Other developments 333 14.1.15 BIOPANDA REAGENTS LTD 334 14.1.15.1 Business overview 334 14.1.15.2 Products offered 334 14.2 OTHER PLAYERS 338 14.2.1 FASSISI, GMBH 338 14.2.2 SKYER, INC. 339 14.2.3 GOLD STANDARD DIAGNOSTICS 340 14.2.4 BIO-X DIAGNOSTICS S.A. 341 14.2.5 AFFIGEN INC. 342 14.2.6 ALVEO TECHNOLOGIES 343 14.2.7 FLUXERGY INC. 344 14.2.8 WOODLEY EQUIPMENT COMPANY LTD 345 14.2.9 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD. 346 14.2.10 CORIS BIOCONCEPT 347 15 RESEARCH METHODOLOGY 348 15.1 RESEARCH APPROACH 348 15.2 RESEARCH METHODOLOGY DESIGN 348 15.2.1 SECONDARY RESEARCH 349 15.2.1.1 Key data from secondary sources 350 15.2.2 PRIMARY DATA 350 15.2.2.1 Key data from primary sources 351 15.2.2.2 Key industry insights 352 15.3 MARKET SIZE ESTIMATION 354 15.3.1 BOTTOM-UP APPROACH 360 15.4 DATA TRIANGULATION 361 15.5 MARKET SHARE ESTIMATION 362 15.6 RESEARCH ASSUMPTIONS 362   15.7 RESEARCH LIMITATIONS 362 15.7.1 METHODOLOGY-RELATED LIMITATIONS 362 15.7.2 SCOPE-RELATED LIMITATIONS 363 15.8 RISK ASSESSMENT 363 16 APPENDIX 364 16.1 DISCUSSION GUIDE 364 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 368 16.3 CUSTOMIZATION OPTIONS 370 16.3.1 PRODUCT ANALYSIS 370 16.3.2 COMPANY INFORMATION 370 16.3.3 GEOGRAPHIC ANALYSIS 370 16.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 370 16.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE 370 16.3.6 BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 370 16.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 370 16.4 RELATED REPORTS 371 16.5 AUTHOR DETAILS 372
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 36 TABLE 2 NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION) 51 TABLE 3 VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 61 TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 64 TABLE 5 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 69 TABLE 6 PRICING TREND OF PCR KITS, BY REGION, 2023−2025 70 TABLE 7 PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023−2025 70 TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 72 TABLE 9 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 72 TABLE 10 VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026–2027 73 TABLE 11 CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES 76 TABLE 12 CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION 77 TABLE 13 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION 77 TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES 79 TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS 79 TABLE 16 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA 80 TABLE 17 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA 80 TABLE 18 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK 81 TABLE 19 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO 81 TABLE 20 VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS 89 TABLE 21 KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS 93 TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 101 TABLE 28 KEY BUYING CRITERIA FOR TOP 3 END USERS 102 TABLE 29 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 107 TABLE 30 VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108 TABLE 31 KEY PLAYERS PROVIDING CONSUMABLES 109 TABLE 32 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 33 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 111 TABLE 34 KEY PLAYERS PROVIDING INSTRUMENTS 112 TABLE 35 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 36 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 114 TABLE 37 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 116 TABLE 38 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS 117 TABLE 39 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118 TABLE 40 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 41 DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 42 CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 43 HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 44 OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 45 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK 126 TABLE 46 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 47 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 48 CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 49 PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 50 POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 51 OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 52 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 136 TABLE 53 KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS 137 TABLE 54 IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 55 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS 140 TABLE 56 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 57 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 58 PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 59 ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 60 CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 61 OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 62 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 63 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 152 TABLE 64 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 65 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 153 TABLE 66 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 153 TABLE 67 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 154 TABLE 68 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 154 TABLE 69 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 154 TABLE 70 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 155 TABLE 71 US: KEY MACRO INDICATORS 156 TABLE 72 US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 156 TABLE 73 US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 156 TABLE 74 US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 157 TABLE 75 US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 157 TABLE 76 US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 157 TABLE 77 US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 158 TABLE 78 CANADA: KEY MACRO INDICATORS 159 TABLE 79 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 159 TABLE 80 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 159 TABLE 81 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 160 TABLE 82 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 160 TABLE 83 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 160 TABLE 84 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 161 TABLE 85 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 162 TABLE 86 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 87 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 163 TABLE 88 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 164 TABLE 89 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 164 TABLE 90 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 164 TABLE 91 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 165 TABLE 92 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 165 TABLE 93 GERMANY: KEY MACRO INDICATORS 166 TABLE 94 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 167 TABLE 95 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 167 TABLE 96 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 167 TABLE 97 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 168 TABLE 98 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 168 TABLE 99 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 168 TABLE 100 UK: KEY MACRO INDICATORS 170 TABLE 101 UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 170 TABLE 102 UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 170 TABLE 103 UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 171 TABLE 104 UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 171 TABLE 105 UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 171 TABLE 106 UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 172 TABLE 107 FRANCE: KEY MACRO INDICATORS 172 TABLE 108 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 173 TABLE 109 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 173 TABLE 110 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 173 TABLE 111 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 174 TABLE 112 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 174 TABLE 113 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 174 TABLE 114 ITALY: KEY MACRO INDICATORS 175 TABLE 115 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 176 TABLE 116 ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 176 TABLE 117 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 176 TABLE 118 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 177 TABLE 119 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 177 TABLE 120 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 177 TABLE 121 SPAIN: KEY MACRO INDICATORS 178 TABLE 122 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 178 TABLE 123 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 179 TABLE 124 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 179 TABLE 125 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 179 TABLE 126 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 180 TABLE 127 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 180 TABLE 128 NETHERLANDS: KEY MACRO INDICATORS 181 TABLE 129 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 181 TABLE 130 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 182 TABLE 131 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 182 TABLE 132 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 182 TABLE 133 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 183 TABLE 134 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 183 TABLE 135 POLAND: KEY MACRO INDICATORS 184 TABLE 136 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184 TABLE 137 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 185 TABLE 138 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 185 TABLE 139 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 185 TABLE 140 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 186 TABLE 141 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 186 TABLE 142 SWEDEN: KEY MACRO INDICATORS 187 TABLE 143 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 187 TABLE 144 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 187 TABLE 145 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 188 TABLE 146 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 188 TABLE 147 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 188 TABLE 148 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 189 TABLE 149 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189 TABLE 150 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 190 TABLE 151 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 190 TABLE 152 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 190 TABLE 153 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 191 TABLE 154 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 191 TABLE 155 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 194 TABLE 156 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 157 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195 TABLE 158 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 196 TABLE 159 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 196 TABLE 160 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 196 TABLE 161 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 197 TABLE 162 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 197 TABLE 163 CHINA: KEY MACRO INDICATORS 198 TABLE 164 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198 TABLE 165 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 199 TABLE 166 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 199 TABLE 167 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 199 TABLE 168 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 200 TABLE 169 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 200 TABLE 170 JAPAN: KEY MACRO INDICATORS 201 TABLE 171 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 202 TABLE 172 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 202 TABLE 173 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 202 TABLE 174 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 203 TABLE 175 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 203 TABLE 176 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 203 TABLE 177 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 205 TABLE 178 INDIA: KEY MACRO INDICATORS 205 TABLE 179 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 205 TABLE 180 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 206 TABLE 181 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 206 TABLE 182 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 206 TABLE 183 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 207 TABLE 184 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 207 TABLE 185 AUSTRALIA: KEY MACRO INDICATORS 208 TABLE 186 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 208 TABLE 187 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 209 TABLE 188 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 209 TABLE 189 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 209 TABLE 190 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 210 TABLE 191 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 210 TABLE 192 SOUTH KOREA: KEY MACRO INDICATORS 211 TABLE 193 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 211 TABLE 194 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 211 TABLE 195 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 212 TABLE 196 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 212 TABLE 197 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 212 TABLE 198 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 213 TABLE 199 NEW ZEALAND: KEY MACRO INDICATORS 213 TABLE 200 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 214 TABLE 201 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 214 TABLE 202 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 214 TABLE 203 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 215 TABLE 204 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 215 TABLE 205 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 215 TABLE 206 THAILAND: KEY MACRO INDICATORS 216 TABLE 207 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 217 TABLE 208 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 217 TABLE 209 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 217 TABLE 210 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 218 TABLE 211 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 218 TABLE 212 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 218 TABLE 213 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 219 TABLE 214 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 219 TABLE 215 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 220 TABLE 216 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 220 TABLE 217 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 221 TABLE 218 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 221 TABLE 219 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 222 TABLE 220 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 221 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 223 TABLE 222 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 223 TABLE 223 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 224 TABLE 224 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 224 TABLE 225 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 224 TABLE 226 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 225 TABLE 227 BRAZIL: KEY MACRO INDICATORS 226 TABLE 228 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 226 TABLE 229 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 226 TABLE 230 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 227 TABLE 231 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 227 TABLE 232 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 227 TABLE 233 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 228 TABLE 234 MEXICO: KEY MACRO INDICATORS 228 TABLE 235 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 229 TABLE 236 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 229 TABLE 237 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 229 TABLE 238 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 230 TABLE 239 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 230 TABLE 240 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 230 TABLE 241 ARGENTINA: KEY MACRO INDICATORS 231 TABLE 242 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 232 TABLE 243 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 232 TABLE 244 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 232 TABLE 245 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 233 TABLE 246 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 233 TABLE 247 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 233 TABLE 248 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 234 TABLE 249 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 234 TABLE 250 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 235 TABLE 251 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 235 TABLE 252 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 235 TABLE 253 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 236 TABLE 254 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 237 TABLE 255 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 256 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 238 TABLE 257 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 238 TABLE 258 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 239 TABLE 259 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 239 TABLE 260 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 239 TABLE 261 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 240 TABLE 262 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 263 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 241 TABLE 264 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 241 TABLE 265 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 241 TABLE 266 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 242 TABLE 267 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 242 TABLE 268 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 242 TABLE 269 KINGDOM OF SAUDI ARABIA (KSA): KEY MACRO INDICATORS 243 TABLE 270 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 243 TABLE 271 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 244 TABLE 272 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 244 TABLE 273 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 244 TABLE 274 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 245 TABLE 275 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 245 TABLE 276 UNITED ARAB EMIRATES (UAE): KEY MACRO INDICATORS 246 TABLE 277 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 246 TABLE 278 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 246 TABLE 279 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 247 TABLE 280 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 247 TABLE 281 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 247 TABLE 282 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 248 TABLE 283 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 248 TABLE 284 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 249 TABLE 285 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 249 TABLE 286 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 249 TABLE 287 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 250 TABLE 288 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 250 TABLE 289 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 251 TABLE 290 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 251 TABLE 291 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 251 TABLE 292 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 252 TABLE 293 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 252 TABLE 294 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 252 TABLE 295 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET 253 TABLE 296 VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 258 TABLE 297 US VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 259 TABLE 298 EUROPE VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 260 TABLE 299 VETERINARY POC DIAGNOSTICS MARKET: REGION FOOTPRINT 264 TABLE 300 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT FOOTPRINT 265 TABLE 301 VETERINARY POC DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT 266 TABLE 302 VETERINARY POC DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT 267 TABLE 303 VETERINARY POC DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 269 TABLE 304 VETERINARY POC DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 270 TABLE 305 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022–MAY 2026 273 TABLE 306 VETERINARY POC DIAGNOSTICS MARKET: DEALS, JANUARY 2022–APRIL 2026 274 TABLE 307 VETERINARY POC DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–APRIL 2026 275 TABLE 308 VETERINARY POC DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2026 276 TABLE 309 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 277 TABLE 310 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 279 TABLE 311 IDEXX LABORATORIES, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 279 TABLE 312 ZOETIS SERVICES LLC: COMPANY OVERVIEW 281 TABLE 313 ZOETIS SERVICES LLC: PRODUCTS OFFERED 282 TABLE 314 ZOETIS SERVICES LLC: DEALS 283 TABLE 315 ZOETIS SERVICES LLC: EXPANSIONS 283 TABLE 316 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS 284 TABLE 317 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 286 TABLE 318 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 287 TABLE 319 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW 292 TABLE 320 ANTECH DIAGNOSTICS, INC.: PRODUCTS OFFERED 293 TABLE 321 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 293 TABLE 322 ANTECH DIAGNOSTICS, INC.: EXPANSIONS 294 TABLE 323 BIONOTE: COMPANY OVERVIEW 296 TABLE 324 BIONOTE: PRODUCTS OFFERED 296 TABLE 325 BIONOTE: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 298 TABLE 326 BIONOTE: DEALS 299 TABLE 327 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 301 TABLE 328 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED 301 TABLE 329 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS 302 TABLE 330 BIOMÉRIEUX: COMPANY OVERVIEW 303 TABLE 331 BIOMÉRIEUX: PRODUCTS OFFERED 304 TABLE 332 BIOMÉRIEUX: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 305 TABLE 333 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 306 TABLE 334 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED 306 TABLE 335 INDICAL BIOSCIENCE GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 308 TABLE 336 VIRBAC: COMPANY OVERVIEW 309 TABLE 337 VIRBAC: PRODUCTS OFFERED 310 TABLE 338 VIRBAC: DEALS 311 TABLE 339 VIRBAC: EXPANSIONS 311 TABLE 340 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW 312 TABLE 341 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED 312 TABLE 342 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 315 TABLE 343 BIOGAL: COMPANY OVERVIEW 316 TABLE 344 BIOGAL: PRODUCTS OFFERED 316 TABLE 345 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 318 TABLE 346 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 318 TABLE 347 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 325 TABLE 348 RING BIOTECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS 325 TABLE 349 AGROLABO S.P.A.: COMPANY OVERVIEW 326 TABLE 350 AGROLABO S.P.A.: PRODUCTS OFFERED 326 TABLE 351 ENALEES: COMPANY OVERVIEW 328 TABLE 352 ENALEES: PRODUCTS OFFERED 328 TABLE 353 ENALEES: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 331 TABLE 354 ENALEES: DEALS 331 TABLE 355 ENALEES: EXPANSIONS 332 TABLE 356 ENALEES: OTHER DEVELOPMENTS 333 TABLE 357 BIOPANDA REAGENTS LTD: COMPANY OVERVIEW 334 TABLE 358 BIOPANDA REAGENTS LTD: PRODUCTS OFFERED 334 TABLE 359 FASSISI, GMBH: COMPANY OVERVIEW 338 TABLE 360 SKYER, INC.: COMPANY OVERVIEW 339 TABLE 361 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 340 TABLE 362 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW 341 TABLE 363 AFFIGEN INC.: COMPANY OVERVIEW 342 TABLE 364 ALVEO TECHNOLOGIES: COMPANY OVERVIEW 343 TABLE 365 FLUXERGY INC.: COMPANY OVERVIEW 344 TABLE 366 WOODLEY EQUIPMENT COMPANY LTD: COMPANY OVERVIEW 345 TABLE 367 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW 346 TABLE 368 CORIS BIOCONCEPT: COMPANY OVERVIEW 347 TABLE 369 VETERINARY POC DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS 362 TABLE 370 VETERINARY POC DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS 363 FIGURE 1 VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE 34 FIGURE 2 MARKET SCENARIO 38 FIGURE 3 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024–2031 39 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020–2025 39 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET 40 FIGURE 6 HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET, 2026–2031 41 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 42 FIGURE 8 INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH 44 FIGURE 9 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 45 FIGURE 10 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 46 FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 47 FIGURE 13 VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48 FIGURE 14 PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD) 53 FIGURE 15 VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS 61 FIGURE 16 VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 17 VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS 68 FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75 FIGURE 19 VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO 76 FIGURE 20 VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015–MAY 2026) 88 FIGURE 21 TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015–FEBRUARY 2026) 89 FIGURE 22 ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION 92 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 101 FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS 102 FIGURE 25 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 149 FIGURE 26 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030 151 FIGURE 27 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT 152 FIGURE 28 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 192 FIGURE 29 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 193 FIGURE 30 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT 194 FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021−2025) 256 FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 257 FIGURE 33 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 259 FIGURE 34 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 260 FIGURE 35 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 262 FIGURE 36 VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT 263 FIGURE 37 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 268 FIGURE 38 VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 271 FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022−2025 272 FIGURE 40 EV/EBITDA OF KEY VENDORS 272 FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 273 FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT 278 FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT 282 FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 287 FIGURE 45 BIOMÉRIEUX: COMPANY SNAPSHOT 304 FIGURE 46 VIRBAC: COMPANY SNAPSHOT 310 FIGURE 47 VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN 348 FIGURE 48 DATA OBTAINED FROM SECONDARY SOURCES 350 FIGURE 49 PRIMARY SOURCES 350 FIGURE 50 DATA OBTAINED FROM PRIMARY SOURCES 351 FIGURE 51 EXPERT INSIGHTS 352 FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 352 FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 353 FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 353 FIGURE 55 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 354 FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 355 FIGURE 57 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024) 355 FIGURE 58 VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS 357 FIGURE 59 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026–2031) 358 FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 359 FIGURE 61 TOP-DOWN APPROACH 359 FIGURE 62 BOTTOM-UP APPROACH 360 FIGURE 63 MARKET DATA TRIANGULATION METHODOLOGY 361

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們